Point72 Hong Kong’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65K | Buy |
+7,991
| New | +$65K | ﹤0.01% | 352 |
|
|
2024
Q4 | – | Sell |
-3,100
| Closed | -$47.4K | – | 576 |
|
|
2024
Q3 | $47.4K | Buy |
+3,100
| New | +$47.4K | ﹤0.01% | 366 |
|
|
2022
Q2 | – | Sell |
-7,774
| Closed | -$245K | – | 1839 |
|
|
2022
Q1 | $245K | Buy |
7,774
+7,325
| +1,631% | +$231K | 0.01% | 434 |
|
|
2021
Q4 | $18K | Buy |
+449
| New | +$18K | ﹤0.01% | 1015 |
|
|
2021
Q2 | – | Sell |
-1,202
| Closed | -$34K | – | 1711 |
|
|
2021
Q1 | $34K | Buy |
+1,202
| New | +$34K | ﹤0.01% | 854 |
|
|
2020
Q3 | – | Sell |
-12,406
| Closed | -$307K | – | 1465 |
|
|
2020
Q2 | $307K | Buy |
+12,406
| New | +$307K | 0.03% | 426 |
|
|
2018
Q2 | – | Sell |
-7,656
| Closed | -$118K | – | 1133 |
|
|
2018
Q1 | $118K | Buy |
+7,656
| New | +$118K | 0.06% | 276 |
|